Evidence map›Paper›PMID 41000609›Full record

ReviewRSC advances2025

2D materials for nutraceutical delivery and smart packaging: multifunctional, sustainable, and responsive applications.

Dinithi Senanayake, Imalka Munaweera

Abstract readReview
In one paragraph

Review in RSC advances, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Dinithi SenanayakeDepartment of Chemistry, Faculty of Applied Sciences, University of Sri Jayewardenepura Sri Lanka dinithisenanayake3@gmail.com imalka@sjp.ac.lk.ORCID https://orcid.org/0009-0008-1551-836X
Imalka MunaweeraDepartment of Chemistry, Faculty of Applied Sciences, University of Sri Jayewardenepura Sri Lanka dinithisenanayake3@gmail.com imalka@sjp.ac.lk.ORCID https://orcid.org/0000-0002-0665-1563

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Materials in the form of two-dimensional (2D) structures have recently become a revolutionary platform in nutraceutical delivery and smart food packaging, solving the problem of poor solubility, stability, and bioavailability of bioactive compounds. Traditional delivery systems are not always effective in preventing the degradation of sensitive nutraceuticals like polyphenols, flavonoids, vitamins, and probiotics in response to light, heat, pH changes, or enzyme activity, which reduces their therapeutic potential. Similarly, conventional packaging materials offer little protection and no active food freshness monitoring, which leads to shorter shelf life and poor quality. The novelty of this review is the focus on the multifunctional potential of 2D materials in improving nutraceutical delivery and allowing smart, antimicrobial packaging with targeted, responsive, and sustainable applications. In contrast to the existing reviews that mainly focus on biomedical or pharmaceutical applications, this review summarizes nutraceutical-specific advances, critically evaluates various 2D materials, including graphene and graphene derivatives, MXenes, layered double hydroxides (LDHs), transition metal dichalcogenides (TMDs), and 2D metal-organic frameworks (MOFs), and points out regulatory, toxicological, and sustainability issues that are essential to real-world translation. Recent reports indicate that 2D materials can be used to efficiently encapsulate bioactives and enhance solubility, chemical stability, and controlled or stimuli-responsive release. In addition, these materials offer antimicrobial, antioxidant and sensing properties to packaging, allowing real-time monitoring and extended shelf life. Collectively, these features turn traditional delivery and packaging into smart, multifunctional platforms. Although these developments have been made, there are still challenges such as the possibility of biosafety issues, lack of standard procedures, regulatory frameworks, and challenges of scalable production. The future outlook focuses on the development of safe, biodegradable, and commercially viable 2D materials, along with standardized evaluation platforms, to provide sustainable, effective, and market-ready nutraceutical delivery and smart packaging solutions.

Identifiers

PMID41000609
PMCPMC12459657

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.